GALT
Galectin Therapeutics Inc.Data: 2026-08-24
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Quick Stats
Aug 24, 202639.7
AI Score
EXTENDED0.35
Volume Ratio
TBA
Next Earnings
16
+ve Days (30d)
14
-ve Days (30d)
GALT Stock Summary
Last updated Aug 24, 2026
GALT is currently trading at $3.9684, positioned above its 200-day moving average of $3.51, indicating a long-term uptrend. The stock has a 52-week range of $2.025 to $7.13.
Technical Analysis: The 50-day moving average stands at $3.7, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 58.837, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.137, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates GALT at 39.7/100 with a EXTENDED recommendation.
GALT (Galectin Therapeutics Inc.) Indicators
Last updated Aug 24, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 58.837 |
| CMF (20) | 0.137 |
| ROC (10) | 24.038 |
| ADX (14) | 18.086 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.023 |
| AROONOSC (14) | 100.0 |
| WILLAMS %R (14) | -3.723 |
| MFI (14) | 63.743 |
GALT Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
GALT Price vs Max Options Open Interest
GALT Max Change In Options Open Interest
GALT Options - Sort by Max open Interest (near term)
24th August 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GALT Daily Out of Money Options - Sort by Max open Interest (near term)
24th August 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GALT Daily In the Money Options - Sort by Max open Interest (near term)
24th August 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GALT Most Active Options by Volume(near term)
24th August 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Galectin Therapeutics Inc. is above both the 50 Day and 200 Day SMA which is considered Bullish.
GALT Moving Averages Analysis
Galectin Therapeutics Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Aug 24, 2026
Galectin Therapeutics Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Aug 24, 2026
GALT (Galectin Therapeutics Inc.) Simple Moving Averages
Moving Averages are last updated Aug 24, 2026
| Days | MA |
|---|---|
| 10 | 3.52 |
| 20 | 3.36 |
| 30 | 3.58 |
| 50 | 3.7 |
| 100 | 3.04 |
| 200 | 3.51 |
GALT Fundamental Analysis
| P/E (Forward) | 4.5434 |
| P/E (Trailing) | -- |
| Market Cap ($) | 360.0 million |
| Earnings/Share ($) | -0.42 |
| Net Profit Margin (%) | -- |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.3 |
| EPS Estimate Next Year ($) | -0.23 |
| WallStreet Target Price ($) | 11.00 |
| Most Recent Quarter |